Biofrontera (BFRI) Treasury Shares (2021 - 2025)
Biofrontera's (BFRI) quarterly Treasury Shares came in at $412500.0 in Q4 2025, down 8.33% year-on-year from $450000.0 in Q4 2024, and little changed quarter-over-quarter from $412500.0 in Q3 2025.
Biofrontera (BFRI) Treasury Shares (2021 - 2025) Analysis & Trends
Biofrontera's Treasury Shares history runs 5 years deep, the most recent figure standing at $412500.0 for Q4 2025.
- On a quarterly basis, Treasury Shares fell 8.33% year-over-year to $412500.0 in Q4 2025; TTM through Dec 2025 was $412500.0, a 8.33% decrease from a year earlier, with the FY2025 full-year figure at $412500.0, down 8.33% from the prior year.
- Treasury Shares was little changed at $412500.0 in Q4 2025 per BFRI's latest filing, from $412500.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $343.5 million in Q2 2022 and bottomed at $4771.0 in Q2 2023.
- The 5-year median for Treasury Shares is $343512.0 (2022), against an average of $23.1 million.
- Across the five-year window, Treasury Shares sank 100.0% in 2023 and surged 9331.98% in 2024, its largest moves.
- Year by year, Treasury Shares stood at $8504.0 in 2021, then surged by 101.98% to $17176.0 in 2022, then plunged by 72.22% to $4771.0 in 2023, then jumped by 9331.98% to $450000.0 in 2024, then retreated by 8.33% to $412500.0 in 2025.
- Per Business Quant, the three latest BFRI Treasury Shares figures stand at $412500.0 (Q4 2025), $412500.0 (Q3 2025), and $450000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Biofrontera | 12.70 Mn | 6.29 Mn | 14.09 Mn | 412,500.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 412,500.00 |
| Dec 31, 2025 | 412,500.00 |
| Sep 30, 2025 | 412,500.00 |
| Sep 30, 2025 | 412,500.00 |
| Jun 30, 2025 | 450,000.00 |
| Jun 30, 2025 | 450,000.00 |
| Mar 31, 2025 | 450,000.00 |
| Mar 31, 2025 | 450,000.00 |
| Dec 31, 2024 | 450,000.00 |
| Dec 31, 2024 | 450,000.00 |
| Sep 30, 2024 | 450,000.00 |
| Sep 30, 2024 | 450,000.00 |
| Mar 31, 2024 | 4,806.00 |
| Mar 31, 2024 | 4,806.00 |
| Dec 31, 2023 | 4,771.00 |
| Dec 31, 2023 | 4,771.00 |
| Sep 30, 2023 | 4,771.00 |
| Sep 30, 2023 | 4,771.00 |
| Jun 30, 2023 | 4,771.00 |
| Jun 30, 2023 | 4,771.00 |